Scleroderma lung disease

Eur Respir Rev. 2013 Mar 1;22(127):6-19. doi: 10.1183/09059180.00005512.
No abstract available

Publication types

  • Review

MeSH terms

  • Humans
  • Hypertension, Pulmonary / diagnosis
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / mortality
  • Hypertension, Pulmonary / physiopathology
  • Lung / drug effects*
  • Lung / pathology
  • Lung / physiopathology
  • Lung Diseases, Interstitial / diagnosis
  • Lung Diseases, Interstitial / drug therapy*
  • Lung Diseases, Interstitial / mortality
  • Lung Diseases, Interstitial / physiopathology
  • Lung Transplantation
  • Predictive Value of Tests
  • Respiratory System Agents / adverse effects
  • Respiratory System Agents / therapeutic use*
  • Risk Factors
  • Scleroderma, Systemic / diagnosis
  • Scleroderma, Systemic / drug therapy*
  • Scleroderma, Systemic / mortality
  • Scleroderma, Systemic / physiopathology
  • Treatment Outcome

Substances

  • Respiratory System Agents